• Profile
Close

Human immunodeficiency virus antiretroviral resistance and transmission in mother-infant pairs enrolled in a large perinatal study

Clinical Infectious Diseases May 29, 2018

Yeganeh N, et al. - Researchers aimed at evaluating the prevalence and the effect of antiretroviral drug-associated resistance mutations (DRMs) in previously untreated mother-infant pairs. Using a case-control design of 1:4 (1 transmitter to 4 nontransmitters), they evaluated DRMs as a predictor of human immunodeficiency virus (HIV) mother-to-child transmission (MTCT) in specimens obtained from mother-infant pairs. They performed ViroSeq HIV-1 genotyping on mother-infant specimens to assess for clinically relevant DRMs. Findings suggested a common occurrence of preexisting DRMs in untreated HIV-infected pregnant women, but it did not increase the risk of HIV MTCT. However, women with DRMs with no virological suppression could transmit resistant mutations, complicating infant management.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay